Latham & Watkins advised Grünenthal on the offering. Grünenthal GmbH announced the pricing of €300 million aggregate principal amount of 6.75% senior secured notes due 2030. The...
Grünenthal’s €300 Million Notes Offering
Grünenthal Pharma GmbH & Co. KG’s €500 Million Financing
Freshfields Bruckhaus Deringer advised Grünenthal Pharma GmbH & Co. KG. The €500 million financing is provided by an international banking syndicate and the transaction provides for an upsize...
Grünenthal’s Joint Venture Collaboration With Kyowa Kirin International
Freshfields Bruckhaus Deringer advised Grünenthal. Allen & Overy advised Kyowa Kirin International. Grünenthal, the Germany-based global leader in pain management and related diseases, on a collaboration...
Grünenthal’s EUR 500 Million Acquisition of Bayer’s Nebido™
Allen & Overy advised Bayer AG on the deal. Freshfields Bruckhaus Deringer advised Grünenthal. Bayer AG sold its men’s health product Nebido™ (testosterone undecanoate) to Grünenthal...
Grünenthal’s €650 Million Bond Offering
Latham & Watkins LLP advised Grünenthal GmbH on the offering. Grünenthal GmbH executed the offering of a bond in two tranches with a total volume of...
Grünenthal GmbH’s Acquisition of Mestex AG
Homburger advised Grünenthal GmbH on this matter, while Vischer advised the sellers of Mestex AG, supported by Orrick, Herrington & Sutcliffe. Grünenthal GmbH announced the acquisition...